Barbara Petzold

Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine

Jens Vollmar, Nathaly Arndtz, Karl M. Eckl et al. · Vaccine · 2005 · 172 citations

Veterinary Medicine, Immunology, Immunization +9

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

Alfred von Krempelhuber, Jens Vollmar, Rolf Pokorny et al. · Vaccine · 2009 · 123 citations · Full text

Veterinary Medicine, Immunology, Immunization +15

Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 <i>Nef</i> -Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption

Ellen G. Harrer, Michael Bäuerle, Barbara Ferstl et al. · Antiviral Therapy · 2005 · 103 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

Ralf G. Meyer, Cedrik M. Britten, U. Siepmann et al. · Cancer Immunology Immunotherapy · 2004 · 65 citations · Full text

Life Sciences, Immunology, Oncology +14